Health care stocks were edging higher pre-bell Friday as the Health Care Select Sector SPDR Fund (XLV) was slightly advancing and the iShares Biotechnology ETF (IBB) was up 0.4% recently.
Viatris (VTRS) shares were down more than 3% after the company said a phase 3 study evaluating the efficacy and safety of MR-139 ophthalmic ointment in subjects with blepharitis did not meet its primary endpoint of complete resolution of debris after six weeks of twice daily dosing.
Telomir Pharmaceuticals (TELO) shares were up more than 153% after the company said its lead candidate Telomir-1 may help restore a tumor suppressor in human prostate cancer cells.
Sarepta Therapeutics (SRPT) shares were down 25% following reports of another patient death in the company's gene therapy trial.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。